Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease

被引:61
作者
Abdelmalek, Manal F.
Liu, Chen
Shuster, Jonathan
Nelson, David R.
Asal, Nabih R.
机构
[1] Univ Florida, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA
[2] Univ Florida, Dept Pathol & Lab Med, Gainesville, FL USA
[3] Univ Florida, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA
[4] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA
关键词
D O I
10.1016/j.cgh.2006.06.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: An association between nonalcoholic fatty liver disease (NAFLD) and the insulin resistance (IR) syndrome exists. Familial clustering of IR may support a genetic predisposition to NAFLD or cryptogenic cirrhosis (cc). Methods: Patients with NAFLD (n = 20) and healthy controls (n = 20) matched for age, sex, and body mass index with at least 4 living relatives and 2 generations of lineage participated in a familial aggregation study. A medical history was obtained from each subject and confirmed with first-degree family members. Results: NAFLD patients were more likely to have cirrhosis (odds ratio [OR] = 12.0), cardiac disease (OR, 3.0), hyperlipidemia (OR 12.1), diabetes mellitus (DM) (OR, 9.1), renal stones (OR, 4.1, and arthritis (OR, 6.1). IR (P =.042) (the primary dependent variable) and DM (P =.013) were noted in their first-degree relatives. A trend for familial clustering of NAFLD or CC (P = .059) with a maternal linkage for disease expression also may exist. Cholelithiasis (P =.047), presumed NAFLD and/or CC (P =.049), and a trend toward IR (P =.07) were noted in the mothers, but not the fathers, of patients with NAFLD. An increased risk of DM (OR, 4.2; 95% confidence interval, 1.26-18.7; P =.013), IR (OR, 2.86; 95% confidence interval, 1.02-9.38; P =.042), and smoking (OR, 3.41; 95% confidence interval, 1.43-9.07; P =.003) was observed in first-degree relatives of NAFLD patients. No significant survival difference was observed between family cohorts. Conclusions: Familial clustering and a potential maternal linkage for IR support a genetic predisposition for NAFLD. Alternatively, the presence of suppressor genes modifying the expression of IR in paternal lineage warrants further investigation.
引用
收藏
页码:1162 / 1169
页数:8
相关论文
共 61 条
  • [1] The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    Adams, LA
    Sanderson, S
    Lindor, KD
    Angulo, P
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (01) : 132 - 138
  • [2] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [3] Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease
    Angelico, F
    Del Ben, M
    Conti, R
    Francioso, S
    Feole, K
    Fiorello, S
    Cavallo, MG
    Zalunardo, B
    Lirussi, F
    Alessandri, C
    Violi, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) : 1578 - 1582
  • [4] Factors associated with gallstone disease in the MICOL experience
    Attili, AF
    Capocaccia, R
    Carulli, N
    Festi, D
    Roda, E
    Barbara, L
    Capocaccia, L
    Menotti, A
    Okolicsanyi, L
    Ricci, G
    Lalloni, L
    Mariotti, S
    Sama, C
    Scafato, E
    Muntoni, S
    Taroni, F
    Morisi, G
    Valente, F
    [J]. HEPATOLOGY, 1997, 26 (04) : 809 - 818
  • [5] Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
    Bedogni, G
    Miglioli, L
    Masutti, F
    Tiribelli, C
    Marchesini, G
    Bellentani, S
    [J]. HEPATOLOGY, 2005, 42 (01) : 44 - 52
  • [6] Second world congress on the insulin resistance syndrome - Insulin resistance syndrome and nonalcoholic fatty liver disease
    Bloomgarden, ZT
    [J]. DIABETES CARE, 2005, 28 (06) : 1518 - 1523
  • [7] Borissova AM, 2003, INT J CLIN PRACT, V57, P258
  • [8] Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
    Brunt, EM
    Janney, CG
    Di Bisceglie, AM
    Neuschwander-Tetri, BA
    Bacon, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) : 2467 - 2474
  • [9] Insulin resistance: A metabolic pathway to chronic liver disease
    Bugianesi, E
    McCullough, AJ
    Marchesini, G
    [J]. HEPATOLOGY, 2005, 42 (05) : 987 - 1000
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497